Ding Ming, Ph.D.

Vice President, Research & Innovation

Anthony Lakavage

Ding Ming, Ph.D., is Vice President, Research & Innovation, for USP. Dr. Ming is responsible for creating a Research and Innovation infrastructure, identifying and supporting new technologies and capabilities relevant to USP standard-setting processes and allied programs, recognizing, evaluating and developing new opportunities that respond to the needs of USP's stakeholders, and enhancing the vision and mission of USP.

With more than nineteen years of pharmaceutical industry experience in scientific, medical and clinical affairs, research and development, global wellness, and consumer healthcare, Dr. Ming joins USP after most recently serving as Global Wellness Category Medical Director at GlaxoSmithKline Consumer Healthcare. Previously, Dr. Ming was APAC Regional Medical Head at GlaxoSmithKline – China. Prior to his work at GSK, Dr. Ming served in various scientific, medical, and clinical leadership capacities at Boehringer Ingelheim Pharmaceutical, Inc., Schering-Plough, Pfizer, and Novartis. In addition, he has provided scientific counsel to regulatory agencies around the world.

Dr. Ming earned his Bachelor of Science Degree in Biology from Inner Mongolia University (China), his Master of Science Degree in Biochemistry from the Chinese Academy of Sciences, and his Ph.D. in Animal Health and Biomedical Sciences from the University of Wisconsin-Madison. A former Dana Farber Fellow of Immunology at Harvard Medical School, Dr. Ming also completed a postdoctoral fellowship in Pharmacology at the Howard Hughes Medical Institute of Mount Sinai Medical Center, New York University. In addition to holding several US and EU patents, Dr. Ming served in scientific organizations that include the International Life Science Institute North America (ILSI-NA) and the Consumer Healthcare Product Association (CHPA).